Full Text View
Tabular View
No Study Results Posted
Related Studies
Perinatal Infections in Pakistan
This study has been completed.
First Received: October 7, 2003   Last Updated: December 4, 2008   History of Changes
Sponsors and Collaborators: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Global Network for Women's and Children's Health Research
Bill and Melinda Gates Foundation
John E. Fogarty International Center (FIC)
National Center for Complementary and Alternative Medicine (NCCAM)
National Institute of Dental and Craniofacial Research (NIDCR)
National Cancer Institute (NCI)
RTI International
University of Alabama at Birmingham
Aga Khan University
Information provided by: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
ClinicalTrials.gov Identifier: NCT00070746
  Purpose

There are large differences in health outcomes related to pregnancy and birth between developed and developing countries. This study will investigate how infections, medical history, health care behavior and psychosocial issues are associated with pregnancy outcomes in Pakistan.


Condition
Bacterial Vaginosis
Fetal Membranes, Premature Rupture
Chorioamnionitis
Pregnancy

Study Type: Observational
Study Design: Prospective
Official Title: Perinatal Infections and Pregnancy Outcomes in Pakistan: A Collaborative Research Project in Partnership With the University of Alabama, USA

Further study details as provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):

Estimated Enrollment: 1500
Study Start Date: June 2003
Estimated Study Completion Date: July 2005
Detailed Description:

Pakistan, the world's seventh most populous country of about 138 million people, is beset with severe problems in its maternal and child health sector. The official maternal mortality ratio for Pakistan is reported as 340 per 100,000 live births. The overall goal to conduct a prospective observational study to identify the risk factors for adverse pregnancy outcomes including reproductive tract infections such as BV, and other physical, dental, nutritional, psychosocial, and behavioral characteristics. The primary objective is to examine the association between BV in pregnant women at 20-26 weeks gestation and various other biochemical infection markers with adverse pregnancy outcomes (i.e., perinatal mortality [PNM], neonatal mortality, low birth weight [LBW], spontaneous preterm delivery [SPTD], premature rupture of membranes [PROM], histological chorioamnionitis).

Additionally, this study will explore the relationship of various health behaviors and health status to the presence of perinatal infections. A total of 1,500 pregnant women will be enrolled in the study. A matched case-control study will be conducted at the end of the data collection period to evaluate the use of markers for the prediction of infection related perinatal mortality and infection related SPTD. All investigators and laboratory personnel will remain blinded to the identity of specimens through the use of unique study identifier numbers. Collected data will then be unblinded, analysed, and correlated with the previously collected demographic, obstetrics, and neonatal outcome, microbiology and histopathological data.

Based on the findings of this study, appropriate interventions to address reproductive tract infection (RTI) could be developed and field-tested in Pakistan. We expect that these interventions, once successfully field-tested, could be widely used to improve maternal and child survival in Pakistan and other developing countries. Given the critical state of maternal and child health in Pakistan, and considering the emerging evidence that infections could lead to poor pregnancy outcomes, this study is extremely relevant and timely, and it has the potential to contribute significantly toward the improvement of reproductive health in Pakistan.

Primary outcome is perinatal mortality. Secondary outcomes include birth weight; spontaneous delivery occurring before 37 weeks gestation; rupture of fetal membranes before 37 weeks of gestation; and maternal death. The sample size was based on 25% prevalence of BV in the control group; 10 percent dropout rate; 80 percent power; and a two-tailed type I error of 0.05.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Participants must

  • be in their 20th to 26th week of pregnancy (to be confirmed by an ultrasound)
  • be permanent residents (resident for the past months or intending to stay for next the 6 months) of the study site in Hyderabad, Pakistan; and,
  • give informed (written or verbal) consent.

Exclusion criteria:

  • have clinical diagnoses of life-threatening conditions (requiring immediate treatment or hospitalization, as diagnosed by the attending physician).
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00070746

Locations
Pakistan
Health clinic
Hyderabad, Pakistan
Sponsors and Collaborators
Global Network for Women's and Children's Health Research
Bill and Melinda Gates Foundation
RTI International
University of Alabama at Birmingham
Aga Khan University
Investigators
Principal Investigator: Robert Goldenberg, MD Drexel University
  More Information

Additional Information:
No publications provided

Study ID Numbers: GN 09, U01 HD40607
Study First Received: October 7, 2003
Last Updated: December 4, 2008
ClinicalTrials.gov Identifier: NCT00070746     History of Changes
Health Authority: United States: Federal Government

Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
Perinatal mortality [PNM]
Neonatal mortality
Low birth weight [LBW]
Spontaneous preterm delivery [SPTD]
Premature rupture of membranes [PROM]
Histological chorioamnionitis
Global Network
Pakistan
Maternal and child health
International
Women's health

Study placed in the following topic categories:
Bacterial Infections
Birth Weight
Pregnancy Complications
Vaginitis
Pregnancy Complications, Infectious
Obstetric Labor Complications
Wounds and Injuries
Rupture
Disorders of Environmental Origin
Vaginal Diseases
Fetal Membranes, Premature Rupture
Genital Diseases, Female
Body Weight
Fetal Diseases
Vaginosis, Bacterial
Chorioamnionitis
Premature Birth

Additional relevant MeSH terms:
Placenta Diseases
Bacterial Infections
Pregnancy Complications
Vaginitis
Obstetric Labor Complications
Wounds and Injuries
Rupture
Disorders of Environmental Origin
Vaginal Diseases
Fetal Membranes, Premature Rupture
Genital Diseases, Female
Fetal Diseases
Vaginosis, Bacterial
Chorioamnionitis

ClinicalTrials.gov processed this record on September 03, 2009